
Wolfe Research upgrades Intellia Therapeutics Inc (NTLA) stock to an Outperform
Intellia Therapeutics Inc’s recently made public that its Director Bhanji Muna unloaded Company’s shares for reported $2252.0 on Apr 29
Intellia Therapeutics Inc’s recently made public that its Director Bhanji Muna unloaded Company’s shares for reported $2252.0 on Apr 29
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Intellia Therapeutics Inc revealed its Director Bhanji Muna unloaded Company’s shares for reported $2252.0 on Apr 29
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Intellia Therapeutics
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Intellia Therapeutics Inc revealed its Director Bhanji Muna unloaded Company’s shares for reported $2252.0 on Apr 29
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Intellia Therapeutics Inc’s filing revealed that its Director Bhanji Muna unloaded Company’s shares for reported $2252.0 on Apr 29 ’25.
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its